CC BY-NC-ND 4.0 · Asian J Neurosurg 2024; 19(03): 478-483
DOI: 10.1055/s-0044-1787777
Original Article

Usefulness and Safety of Gelatin–Thrombin Matrix Sealants in Minimally Invasive Microscopic Discectomy

Yushi Sakamoto
1   Department of Spine Surgery, Naruo Orthopedic Hospital, Kumamoto, Japan
2   Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan
,
Seiichiro Naruo
1   Department of Spine Surgery, Naruo Orthopedic Hospital, Kumamoto, Japan
,
Tomonori Ozaki
1   Department of Spine Surgery, Naruo Orthopedic Hospital, Kumamoto, Japan
,
Shogo Tahata
1   Department of Spine Surgery, Naruo Orthopedic Hospital, Kumamoto, Japan
,
Toru Fujimoto
1   Department of Spine Surgery, Naruo Orthopedic Hospital, Kumamoto, Japan
,
Atushi Ogata
2   Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan
,
Fumitaka Yoshioka
2   Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan
,
Yukiko Nakahara
2   Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan
,
Jun Masuoka
2   Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan
,
Tatsuya Abe
2   Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan
› Author Affiliations
Funding None.

Abstract

Objective This study aimed to evaluate the usefulness and safety of gelatin–thrombin matrix sealants (GTMSs) in minimally invasive microscopic discectomy, a surgical procedure commonly used to treat lumbar disc herniation.

Materials and Methods Out of 484 patients who underwent minimally invasive microscopic discectomy between April 2018 and December 2022, 35 patients with a history of surgery at the same level were excluded, resulting in a total of 449 patients included in the study. Among them, 316 patients were treated using GTMS, whereas 133 were treated using collagen-based absorbable local hemostatic agents. Patient characteristics, surgical duration, intraoperative blood loss, postoperative drainage volume, intraoperative dural injury, and incidence of postoperative epidural hematoma were analyzed and compared between the two groups.

Results No significant differences in patient demographics were observed between the two groups, except for activated partial thromboplastin time and prothrombin time. Although there were no significant differences in the mean surgical time and intraoperative blood loss between the two groups, they tended to be shorter and less in the GTMS group (56.3 ± 20.2 vs. 58.2 ± 20.4 minutes [p = 0.36] and 10.0 ± 15.4 vs. 11.8 ± 8.3 g [p = 0.20]). The volume of postoperative drainage was significantly lower in the GTMS group than that in the comparison group (35.3 ± 21.8 vs. 49.5 ± 34.1 g [p < 0.01]). There was a trend indicating a difference in the number of intraoperative dural injuries and the need for reoperation due to postoperative epidural hematoma (2 vs. 3 ± 20.4 minutes [p = 0.21] and 1 vs. 2 [p = 0.16]).

Conclusion The use of a GTMS in minimally invasive microscopic discectomy appears to be beneficial in reducing postoperative drainage volume. It has also been shown that it may improve clinical outcomes such as intraoperative dural injury and postoperative epidural hematoma. Furthermore, further consideration of the medical economic impact is required.

Authors' Contributions

Y.S. and S.N. designed the study; Y.S., T.O., and S.T. performed the experiments and analyzed the data; T.F., A.O., F.Y., Y.N., J.M., and T.A. conducted manuscript writing and provided guidance for statistical analysis; Y.S., T.O., and T.A. wrote the manuscript.


Ethical Approval

Ethical approval was waived by the ethics committee due to the retrospective study design.


Patients' Consent

Informed consent for all participants in this study was obtained through an opt-out process.




Publication History

Article published online:
12 June 2024

© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine 2008; 33 (22) 2464-2472
  • 2 Jacobs WC, van Tulder M, Arts M. et al. Surgery versus conservative management of sciatica due to a lumbar herniated disc: a systematic review. Eur Spine J 2011; 20 (04) 513-522
  • 3 Angevine PD, McCormick PC. Outcomes research and lumbar discectomy. Neurosurg Focus 2002; 13 (02) E8
  • 4 Mixter W, Barr JS. Rupture of the intervertebral disc with involvement of the spinal canal. N Engl J Med 1934; 211: 1632-1638
  • 5 Yasargil MG. Microsurgical operation of herniated lumbar disc. Adv. Neurosurg 1977; (04) 81-82
  • 6 Foley KT, Smith MM. Microendoscopic discectomy. Tech Neurosurg 1997; 3: 301-307
  • 7 Greiner-Perth R, Böhm H, El Saghir H. Microscopically assisted percutaneous nucleotomy, an alternative minimally invasive procedure for the operative treatment of lumbar disc herniation: preliminary results. Neurosurg Rev 2002; 25 (04) 225-227
  • 8 Nakagawa Y, Yoshida M. Posterior spinal endoscopic surgery and complications, especially postoperative hematoma and its countermeasures. J Spine Res 2013; 4: 7-15
  • 9 Oz MC, Rondinone JF, Shargill NS. FloSeal Matrix: new generation topical hemostatic sealant. J Card Surg 2003; 18 (06) 486-493
  • 10 Li QY, Lee O, Han HS. et al. Efficacy of a topical gelatin-thrombin matrix sealant in reducing postoperative drainage following anterior cervical disectomy and fusion. Asian Spine J 2015; 9 (06) 909-915
  • 11 Nomura K, Yoshida M, Okada M, Nakamura Y, Yawatari K, Nakayama E. Effectiveness of a gelatin-thrombin matrix sealant (Floseal®) for reducing blood loss during microendoscopic decompression surgery for lumbar spinal canal stenosis: a retrospective cohort study. Global Spine J 2023; 13 (03) 764-770
  • 12 Fiss I, Danne M, Stendel R. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery. Neurol Med Chir (Tokyo) 2007; 47 (10) 462-467
  • 13 Yao HH, Hong MK, Drummond KJ. Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant?. J Clin Neurosci 2013; 20 (03) 349-356
  • 14 Brand Y, Narayanan V, Prepageran N, Waran V. A cost-effective delivery system for Floseal during endoscopic and microscopic brain surgery. World Neurosurg 2016; 90: 492-495
  • 15 Echave M, Oyagüez I, Casado MA. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review. BMC Surg 2014; 14: 111
  • 16 Modi HN, Lee DY, Lee SH. Postoperative spinal epidural hematoma after microscopic lumbar decompression: a prospective magnetic resonance imaging study in 89 patients. J Spinal Disord Tech 2011; 24 (03) 146-150
  • 17 Takami M, Yoshida M, Minamide A. et al. Does prophylactic use of topical gelatin-thrombin matrix sealant affect postoperative drainage volume and hematoma formation following microendoscopic spine surgery? A randomized controlled trial. Spine J 2021; 21 (03) 446-454
  • 18 Ramirez MG, Niu X, Epstein J, Yang D. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients. J Med Econ 2018; 21 (10) 1041-1046
  • 19 Ramirez MG, Deutsch H, Khanna N, Cheatem D, Yang D, Kuntze E. Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes. Hosp Pract 2018; 46 (04) 189-196